Issues in designing a randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome: Comment on Wang et al. Randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. Int Urol Nephrol. 2016 ; 48:13–18 (CROSBI ID 245210)
Prilog u časopisu | Pismo uredniku | međunarodna recenzija
Podaci o odgovornosti
Papeš, Dino ; Pasini, Miram ; Jerončić, Ana
engleski
Issues in designing a randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome: Comment on Wang et al. Randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. Int Urol Nephrol. 2016 ; 48:13–18
Issues in designing a randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome
randomized clinical trial ; chronic prostatitis ; chronic pelvic pain syndrome ; methodology ; quality
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
49 (3)
2016.
457-458
objavljeno
0301-1623
10.1007/s11255-016-1356-2
